What is the pathophysiology of sepsis?

Pathophysiology of Sepsis

Sepsis is fundamentally a dysregulated host immune response to infection that triggers simultaneous hyperinflammation and immunosuppression, leading to widespread endothelial dysfunction, microvascular thrombosis, and progressive multi-organ failure. 1

Initial Recognition and Immune Activation

The pathophysiologic cascade begins when the host immune system recognizes pathogen-associated molecular patterns (PAMPs) from invading microorganisms and damage-associated molecular patterns (DAMPs) from injured host tissues. 1

• Pattern recognition receptors including Toll-like receptors (TLRs), dectin 1, and dectin 2 detect microbial glycoproteins, lipoproteins, and nucleic acids on cell surfaces and intracellularly. 1
• These receptors activate signaling pathways that converge on nuclear factor-κB (NF-κB) and interferon regulatory factors (IRFs), triggering production of pro-inflammatory cytokines like TNF and IL-1. 1
• This recognition system involves at least ten different TLRs that exist as homodimers or heterodimers, creating a complex surveillance network. 1

The Biphasic Immune Response

Hyperinflammatory Phase

The initial phase involves overzealous inflammation causing acute organ dysfunction through multiple mechanisms. 2

• Endothelial activation and dysfunction occurs early, with inflammatory mediators disrupting the vascular barrier and promoting fluid extravasation. 3
• Immunothrombosis develops as inflammation and coagulation pathways become intimately linked through the innate immune response, with procoagulant and antifibrinolytic activity leading to widespread microvascular thrombosis. 3, 4
• Early immunothrombotic changes may represent the critical switch point from infection to sepsis. 3

Immunosuppressive Phase

A profound and/or persistent anti-inflammatory response follows, increasing susceptibility to secondary infections. 2

• This immunosuppression can persist long after the initial insult, leaving patients vulnerable to opportunistic pathogens. 2
• The anti-inflammatory response involves upregulation of negative co-stimulatory molecules like PD-1, CTLA-4, TIM-3, and LAG-3 that dampen immune function. 1

Organ System Dysfunction

Cardiovascular System

• Vasodilation occurs due to inflammatory mediators and nitric oxide release, causing distributive shock. 4
• Reduced cardiac output develops from myocardial depression and relative hypovolemia. 4
• Hypotension and shock require fluid resuscitation, vasopressors to maintain mean arterial pressure >65 mmHg, and advanced hemodynamic monitoring. 1, 4

Respiratory System

• Respiratory dysfunction manifests as tachypnea (>20 breaths/minute) and may progress to acute respiratory distress syndrome requiring mechanical ventilation. 1, 4

Renal System

• Renal dysfunction is a frequent manifestation, resulting from hypoperfusion, inflammatory injury, and microvascular thrombosis. 4

Hematologic System

• Thrombocytopenia develops from consumption, sequestration, and impaired production. 4
• Leukocyte abnormalities include either leukocytosis (>12,000/ml) or leukopenia (<4,000/ml), with >10% immature band forms. 1
• The neutrophil-to-lymphocyte ratio may provide additional prognostic information. 4

Hepatic System

• Elevated bilirubin is often a late finding and may cause reductions in production of essential proteins including coagulation factors. 4

Neurologic System

• Neurologic dysfunction results from local endothelial injury and systemic inflammation, potentially mediated through vagus nerve activity. 4
• Altered mental status is a common manifestation of cerebral hypoperfusion and metabolic derangements. 1

Heterogeneity and Modifying Factors

The immune response in sepsis is profoundly heterogeneous, influenced by multiple endogenous and exogenous factors. 2

• Patient-specific factors including genetic makeup, age, sex, comorbidities, metabolic state, prior microbial exposure, and medications all modulate the host response. 2
• This heterogeneity explains why "one-size-fits-all" immunomodulatory treatments have largely failed and why precision medicine approaches using clinical, physiological, microbiological, and molecular ('omics') phenotyping are increasingly necessary. 2

Metabolic and Cellular Abnormalities

In septic shock specifically, underlying circulatory and cellular-metabolic abnormalities are profound enough to substantially increase mortality. 1

• Lactate elevation (>2 mmol/L) reflects tissue hypoperfusion, anaerobic metabolism, and mitochondrial dysfunction. 1
• These metabolic derangements persist even when blood pressure is maintained with vasopressors. 1

Clinical Implications

The translational gap between understanding sepsis pathophysiology and improving clinical diagnosis remains significant. 3

• Many proposed biomarkers lack sufficient specificity and sensitivity for routine clinical use. 3
• The focus has historically been too narrow on inflammatory pathways alone, when the interplay between inflammation, coagulation, and immune dysfunction is critical. 3
• Current evidence-based therapy consists primarily of basic causal measures (antimicrobials) and supportive care (fluids, vasopressors, organ support), while adjuvant interventions like blood purification or targeted immunotherapy remain without definitive proof of effectiveness. 5